Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care

Biden administration appeals Texas court decision striking down free Obamacare coverage of preventive care


The Biden administration on Friday appealed a Texas federal judge’s decision to strike down free Obamacare coverage of preventive health-care services ranging from screenings for certain cancers and diabetes to HIV prevention drugs.

U.S. Judge Reed O’Connor of the U.S. Northern District Court of Texas on Thursday struck down an Obamacare mandate requiring most private insurance plans to cover certain types of health care recommended an independent panel of experts called the Preventive Services Task Force.

“Preventive care is an essential part of health care: it saves lives, saves families money, and improves our nation’s health,” said Kamara Jones, a Health and Human Services spokesperson, on Thursday evening after the judge’s ruling. “Actions that strip away this decade-old protection are backwards and wrong.” 

The case will now go to U.S. Fifth Circuit Court of Appeals. A majority of the judges on that court were appointed by Republican presidents.

HHS estimates that 150 million Americans benefited from the free screenings, counseling, medications and other forms of health care that prevent disease under the Obamacare requirements.

Lawrence Gostin, an expert on health law at Georgetown University, said most private insurance plans will probably continue to cover these services but charge copays and deductibles. Working class Americans will get hit the hardest and might forgo essential health care because they can’t afford the cost, Gostin said.

O’Connor ruled that Obamacare cannot mandate free coverage of health care recommended by the Preventive Services Task Force because the organization’s members were appointed in an illegal manner.

Here is a list of the preventive health services that the judge’s ruling likely applies to

Two business owners and several individuals sued the U.S. in March 2020 over the preventive health services mandate, arguing that buying insurance that covers drugs that prevent HIV infection violates their Christian religious beliefs.

The plaintiffs claimed in their suit that the mandate to cover HIV prevention drugs “forces religious employers to provide coverage for drugs that facilitate and encourage homosexual behavior, prostitution, sexual promiscuity, and intravenous drug use.”

They also argued the Preventive Services Task Force was appointed in an unconstitutional manner and therefore its recommendations cannot serve as the basis of an Obamacare mandate.

This is a developing story. Please check back for updates.

Join CNBC’s Healthy Returns on March 29th, where we’ll convene a virtual gathering of CEOs, scientists, investors and innovators in the health care space to reflect on the progress made today to reinvent the future of medicine. Plus, we’ll have an exclusive rundown of the best investment opportunities in biopharma, health-tech and managed care. Learn more and register today: 



Source

Medical supply firm Medline set to debut after biggest IPO of 2025
Health

Medical supply firm Medline set to debut after biggest IPO of 2025

U.S. medical supplies giant Medline is set to debut on the Nasdaq on Wednesday after the biggest initial public offering of the year.  The private equity-owned company priced at $29 per share on Tuesday, raising $6.26 billion in an upsized offering that finishes off a strong year for new listings and bolsters optimism about the […]

Read More
Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly
Health

Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly

Daniel Grill | Tetra Images | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1 pills for obesity are closer than ever.  2026 is likely the year that two new oral weight loss […]

Read More
Pfizer’s modest 2026 outlook shows its big investments will take time to pay off
Health

Pfizer’s modest 2026 outlook shows its big investments will take time to pay off

Smith Collection | Archive Photos | Getty Images Pfizer on Tuesday forecast modest 2026 guidance as it looks to longer-term investments in its pipeline to counter waning Covid product sales and declines from older drugs. Those hurdles aren’t surprising or new for Pfizer, which has seen a dramatic decline in Covid vaccine and antiviral sales […]

Read More